Patent · US Active

Morphine formulations

US9192608B2 · kind B2 · utility

4Cited by
36References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2015
Grant dateNov 24, 2015
Priority date—
Expiry dateMay 18, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein, generally, are pharmaceutical formulations, e.g., injectable pharmaceutical formulations with improved stability, comprising morphine sulfate or a hydrate thereof, and methods of producing and using the same. Also provided herein are kits comprising the formulations, e.g., injectable morphine formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.